5th TGF-B Targeted Drug Development Summit

Key Topics

• Evaluating the Current Clinical Success & Looking Toward the Future in TGF-β Targeted Therapies
• Utilizing Combination Therapies to Enhance the Function of TGF-β Targeted Therapies
• Unearthing Cutting-Edge Biomarkers & Monitoring the Patient Response to TGF-β Directed Therapies for Improved Patient Selection
• Unlocking the Next Wave of TGF-β Directed Therapies Beyond Immuno-Oncology Towards Clinical Success
• Overcoming TGF-β Therapeutic Toxicity by Design, Dosage & Delivery to Achieve Better Clinical Results
• Employing Improved Animal Models in the Development of TGF-β Directed Therapies for Better Translation
• Investigating Approaches to Improve Translation from Animals to the Clinic for TGF-β Directed Therapies
• Unlocking Alternative Modalities to Direct TGF-β Therapies with Low Immunogenicity & Better Therapeutic Effiacy